Biogen (BIIB) Buildings (2009 - 2025)
Biogen (BIIB) posted quarterly Buildings of $2.1 billion for Q4 2025, up 8.99% year-over-year from $2.0 billion in Q4 2024, and up 8.99% quarter-over-quarter from $2.0 billion in Q4 2024.
Biogen (BIIB) Buildings (2009 - 2025) Analysis & Trends
Biogen's Buildings history runs 17 years deep, the most recent figure standing at $2.1 billion for Q4 2025.
- In Q4 2025, Buildings rose 8.99% year-over-year to $2.1 billion; the TTM figure through Dec 2025 stood at $2.1 billion (up 8.99% YoY), while the FY2025 annual figure was $2.1 billion, up 8.99% from the prior year.
- Buildings for Q4 2025 stood at $2.1 billion, up from $2.0 billion in the prior quarter.
- The five-year high for Buildings was $2.1 billion in Q4 2025, with the low at $1.6 billion in Q4 2022.
- The 5-year median for Buildings is $1.7 billion (2021), against an average of $1.8 billion.
- The sharpest annual moves came in 2021 and 2022: Buildings surged 65.78% in 2021, then declined 6.28% in 2022.
- Biogen's Buildings stood at $1.7 billion in 2021, then dropped by 6.28% to $1.6 billion in 2022, then gained by 0.53% to $1.6 billion in 2023, then advanced by 22.63% to $2.0 billion in 2024, then increased by 8.99% to $2.1 billion in 2025.
- Business Quant data shows BIIB's Buildings at $2.1 billion in Q4 2025, $2.0 billion in Q4 2024, and $1.6 billion in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.14 Bn |
| Dec 31, 2024 | 1.96 Bn |
| Dec 31, 2023 | 1.60 Bn |
| Dec 31, 2022 | 1.59 Bn |
| Dec 31, 2021 | 1.70 Bn |
| Dec 31, 2020 | 1.03 Bn |
| Dec 31, 2019 | 835.00 Mn |
| Dec 31, 2018 | 1.28 Bn |
| Dec 31, 2017 | 1.21 Bn |
| Dec 31, 2016 | 1.11 Bn |
| Dec 31, 2015 | 1.04 Bn |
| Dec 31, 2014 | 947.70 Mn |
| Dec 31, 2013 | 961.50 Mn |
| Dec 31, 2012 | 902.50 Mn |
| Sep 30, 2012 | 839.70 Mn |
| Dec 31, 2011 | 597.90 Mn |
| Dec 31, 2010 | 670.20 Mn |
| Dec 31, 2009 | 669.70 Mn |